FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML Weisberg E et al. - With the widespread onset of drug resistance associated with tyrosine kinase inhibitors, due to mechanisms involving development of point mutations or gene amplification of target proteins, the use of a multi-targeted therapeutic approach is of potential clinical benefit. [more...]
